Collectively, these results highlight the far-reaching consequences of vascular Gabrb3 elimination on the heart and suggest that loss of a common molecule Gabrb3 from the vasculature of the brain and the heart, can contribute concurrently to brain–heart dysfunction. Here, GABRB3 is linked to benign neoplasm.